UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Itron, Inc. (NASDAQ:ITRI - Free Report) by 129.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 732,274 shares of the scientific and technical instruments company's stock after buying an additional 413,487 shares during the quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned about 1.61% of Itron worth $76,713,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently bought and sold shares of ITRI. Janney Montgomery Scott LLC grew its stake in shares of Itron by 0.7% during the 1st quarter. Janney Montgomery Scott LLC now owns 16,795 shares of the scientific and technical instruments company's stock worth $1,759,000 after purchasing an additional 121 shares during the period. Evergreen Capital Management LLC grew its stake in Itron by 3.7% in the 1st quarter. Evergreen Capital Management LLC now owns 3,586 shares of the scientific and technical instruments company's stock valued at $376,000 after acquiring an additional 127 shares during the period. Captrust Financial Advisors grew its stake in Itron by 6.3% in the 4th quarter. Captrust Financial Advisors now owns 2,144 shares of the scientific and technical instruments company's stock valued at $233,000 after acquiring an additional 128 shares during the period. HighTower Advisors LLC grew its stake in Itron by 2.0% in the 1st quarter. HighTower Advisors LLC now owns 7,501 shares of the scientific and technical instruments company's stock valued at $786,000 after acquiring an additional 146 shares during the period. Finally, Pinnacle Wealth Management Advisory Group LLC grew its stake in Itron by 7.3% in the 1st quarter. Pinnacle Wealth Management Advisory Group LLC now owns 2,345 shares of the scientific and technical instruments company's stock valued at $246,000 after acquiring an additional 160 shares during the period. Institutional investors and hedge funds own 96.19% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities research analysts recently issued reports on the stock. Guggenheim reissued a "buy" rating and issued a $155.00 price target (up previously from $133.00) on shares of Itron in a research note on Monday, July 14th. Wall Street Zen raised shares of Itron from a "hold" rating to a "buy" rating in a research note on Saturday, August 2nd. Johnson Rice cut shares of Itron from a "buy" rating to an "accumulate" rating in a research note on Friday, August 1st. TD Cowen lifted their price target on shares of Itron from $139.00 to $145.00 and gave the company a "buy" rating in a research note on Friday, June 20th. Finally, Stephens set a $130.00 price target on shares of Itron in a research note on Monday, August 4th. Ten research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $136.55.
Get Our Latest Stock Report on ITRI
Insider Buying and Selling at Itron
In other news, SVP Justin K. Patrick sold 388 shares of Itron stock in a transaction on Monday, August 25th. The stock was sold at an average price of $125.31, for a total transaction of $48,620.28. Following the transaction, the senior vice president owned 20,761 shares in the company, valued at $2,601,560.91. The trade was a 1.83% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Christopher E. Ware sold 351 shares of Itron stock in a transaction on Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $43,983.81. Following the transaction, the senior vice president owned 19,117 shares in the company, valued at approximately $2,395,551.27. This represents a 1.80% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 3,037 shares of company stock worth $380,566. Corporate insiders own 1.45% of the company's stock.
Itron Trading Up 2.7%
Shares of NASDAQ ITRI traded up $3.18 during trading on Thursday, hitting $121.09. 578,092 shares of the company were exchanged, compared to its average volume of 597,535. Itron, Inc. has a 12-month low of $90.11 and a 12-month high of $140.04. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.75 and a current ratio of 2.04. The company has a fifty day moving average price of $126.65 and a 200-day moving average price of $117.73. The firm has a market capitalization of $5.54 billion, a PE ratio of 20.70, a P/E/G ratio of 0.65 and a beta of 1.46.
Itron (NASDAQ:ITRI - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.33 by $0.29. Itron had a return on equity of 19.69% and a net margin of 11.05%.The business had revenue of $606.76 million for the quarter, compared to analyst estimates of $610.36 million. During the same quarter in the previous year, the firm earned $1.21 EPS. The company's quarterly revenue was down .4% compared to the same quarter last year. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. As a group, equities research analysts expect that Itron, Inc. will post 5.33 EPS for the current year.
About Itron
(
Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Featured Articles

Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.